Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma

Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma

US Patent 6399061 · Granted Jun 4, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Drug conjugates of cMET monoclonal binding agents, and uses thereof2024
CMET monoclonal binding agents, drug conjugates thereof and uses thereof2022
Syndecan-1 (CD138) binding agents and uses thereof2022
Antibody-fynomer conjugates2019
Modified binding molecules comprising connecting peptides2013
Expression and use of anti-CD20 Antibodies2010
Expression and use of anti-CD20 Antibodies2010
Expression and use of anti-CD20 Antibodies2010
Expression and use of anti-CD20 Antibodies2010
Expression and use of anti-CD20 Antibodies2010
Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as the2010
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antib2009